Gnb5 is a negative regulator of the BACE1-mediated Aβ generation and ameliorates cognitive deficits in a mouse model of Alzheimer's disease.
β-Amyloid (Aβ) is generated from the amyloid precursor protein (APP) through sequential cleavage by β-site APP-cleaving enzyme 1 (BACE1) and γ-secretase, where BACE1 acting as the rate-limiting enzyme. Elevated BACE1 levels in the brains of Alzheimer's disease (AD) patients implicate that dysre...
Saved in:
| Main Authors: | Shaokun Chen, Jiechao Zhou, Shuzhong Wang, Erqu Chen, Kai Zhuang, Raozhou Lin, Chensi Liang, Dan Can, Huifang Li, Jing Li, Jie Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-06-01
|
| Series: | PLoS Biology |
| Online Access: | https://doi.org/10.1371/journal.pbio.3003259 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mannose Promotes β‐Amyloid Pathology by Regulating BACE1 Glycosylation in Alzheimer's Disease
by: Chensi Liang, et al.
Published: (2025-03-01) -
RA-PR058, a novel ramalin derivative, reduces BACE1 expression and phosphorylation of tau in Alzheimer’s disease mouse models
by: Yongeun Cho, et al.
Published: (2025-12-01) -
Targeted delivery of BACE1 siRNA for synergistic treatment of Alzheimer's disease
by: Zhaohan Li, et al.
Published: (2025-08-01) -
The BACE‐1 inhibitor CNP520 for prevention trials in Alzheimer's disease
by: Ulf Neumann, et al.
Published: (2018-09-01) -
BACE1 as an early biomarker and its relevance to risk factors for Alzheimer’s disease
by: Masuo Ohno
Published: (2025-10-01)